Since the dissociation constants of radiotracers against albumin in the low micromolar range are higher than those against targeted receptors in the nanomolar range, increased accumulation in tumors can be achieved by conjugating ABM to conventional radiotracers containing a tumor-targeting moiety. The gene discussed is ALB; the disease is neoplasm.